Showing results (321-330 of 635) with videos related to

Sort By:
Pageof 64
Histopathology|July 8, 2020
Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancerKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
Frontiers in Immunology|February 2, 2023
Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC modelRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Future Oncology (London, England)|May 9, 2025
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to accessJesús Garcia-Foncillas, Arnaud Bayle, Dirk Arnold, et al.
Biomedicines|June 28, 2023
An Uncommon Cause of Recurrent Presyncope, Dizziness, and Tachycardia: A Case Report of Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS)Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, et al.
Biomedicines|June 28, 2023
Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic HypoglycemiaMartin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, et al.
Oncotarget|April 23, 2016
Genetic changes of non-small cell lung cancer under neoadjuvant therapyArne Warth, Volker Endris, Albrecht Stenzinger, et al.
Translational Lung Cancer Research|August 25, 2021
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IVWolfgang M Brueckl, Martin Reck, Achim Rittmeyer, et al.
Cancer Research|May 19, 2023
The HDAC2-SP1 Axis Orchestrates Protumor Macrophage PolarizationXiang Zheng, Poonam Sarode, Andreas Weigert, et al.
Scientific Reports|August 13, 2025
In vivo variability of MRI radiomics features in prostate lesions assessed by a test-retest study with repositioningKevin Sun Zhang, Christian Jan Oliver Neelsen, Markus Wennmann, et al.
Pageof 64